Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06166433 · ClinicalTrials.gov registry record · NA
Implementing a Scalable Smoke-free Home Intervention in Armenia and Georgia
A NA study of Second Hand Tobacco Smoke, sponsored by George Washington University.
- Recruiting
- Registry status
- NA
- Development phase
- 550
- Enrollment target
- 1
- Study location
NCT06166433: Recruiting NA study of Second Hand Tobacco Smoke, sponsored by George Washington University.
NCT06166433 is a NA study of Second Hand Tobacco Smoke that is actively recruiting participants, run by George Washington University. The registered enrollment target is 550 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06166433, a NA study of Second Hand Tobacco Smoke, is actively recruiting participants, sponsored by George Washington University.
- RECRUITING
- Registry status
- NA
- Development phase
- 550 participants
- Enrollment target
- 1
- Study location
Study Summary
Tobacco use and secondhand smoke exposure represent critical health disparities in low- and middle-income countries; Armenia and Georgia represent the 11th and 6th highest smoking rates in men globally (51.5% and 55.5%, respectively), but have low rates of smoking in women (1.8% and 7.8%) and few smoke-free homes (38.6%), which can reduce secondhand smoke exposure and tobacco use rates. This study builds on ongoing collaborations between George Washington University, Emory, and national public health organizations in Armenia and Georgia and advancements in local public health infrastructure; it aims to adapt an evidence-based smoke-free home intervention for homes in Armenia and Georgia, develop capacity to deliver the intervention via local community partners and the national quitlines, and test the intervention in a hybrid effectiveness-implementation randomized clinical trial. This work will advance the knowledge base informing strategies to reduce global tobacco-related disparities, as well as the implementation and scale-out of evidence-based interventions in low- and middle-income countries.
Primary Outcome
"Which statement best describes the rules about smoking inside your home: smoking is not allowed anywhere inside my home; smoking is allowed in some places or at some times; smoking is allowed anywhere inside my home; or there are no rules about smoking inside my home." Participant indicates no smoking allowed in the home (in any place or at any time).
Conditions Studied
Interventions
- BEHAVIORAL Smoke-free homes intervention
Study Locations (1)
District of Columbia
- George Washington University - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2025-02-01 |
| Est. Completion | 2027-07-31 |
| Phase | NA |
What NCT06166433 shows while recruiting
NCT06166433 is an interventional study that assigns participants to a tested intervention. The registered 550 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% lower).
The record links to 1 condition, with Second Hand Tobacco Smoke appearing as the primary indexed condition, and to 1 intervention - of which Smoke-free homes intervention is the first listed.
NCT06166433 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT06166433 about?
NCT06166433 is a clinical study titled "Implementing a Scalable Smoke-free Home Intervention in Armenia and Georgia". Tobacco use and secondhand smoke exposure represent critical health disparities in low- and middle-income countries; Armenia and Georgia represent the 11th and 6th highest smoking rates in men globally (51.5% and 55.5%, respectively), but have low rates of smoking in women (1.8% and 7.8%) and few sm...
What is the current status of trial NCT06166433?
This trial is currently recruiting. It is a NA study. The enrollment target is 550 participants. The study started on 2025-02-01. Estimated completion is 2027-07-31.
What conditions does trial NCT06166433 study?
This clinical trial studies the following conditions: Second Hand Tobacco Smoke.
What interventions are being tested in trial NCT06166433?
The interventions under investigation include: Smoke-free homes intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT06166433?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06166433 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Second Hand Tobacco Smoke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06166433's enrollment target sits among peer trials
550 184th of 2000 higher than 1,815 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01852448 · 550 participants
Genetics of Insulin and Incretins in Cystic Fibrosis
- NCT02995252 · 550 participants
The HOPE Study: Characterizing Patients With Hepatitis B and C
- NCT03474913 · 550 participants
Upright MRI for Prostate Cancer Screening
- NCT04761120 · 550 participants
Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI